02.05.2014 • News

Nova Chemicals CEO Woelfel Resigns Post

Randy Woelfel resigned as CEO of Canada's Nova Chemicals on May 1. His departure was announced shortly before the company's first-quarter earnings conference call.

In a statement the Canadian chemical producer said its board of directors and chief executive had been unable to agree on mutually satisfactory contract renewal terms and that the resignation was not due to differences of opinion about Nova's overall business strategy.

Todd Karran, the company's chief financial officer, has been appointed acting CEO to serve until a permanent chief executive has been found. Woelfel had headed Nova since 2009.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read